To counteract the consequences of L-NAME and/or L-arginine administration with the disturbed hemostasis, we administered the stable gastric pentadecapeptide BPC 157 [1,2,1026] not only due to its special effect on hemostasis [1,2], but also owing to a particular beneficial combining [1,2,1014], wound healing capacity [1,2,1017] and particular interaction with NO-system [14,15,1826]
Treatment Duration In patients whose underlying cause of vitamin B12 deficiency has been corrected and are deemed no longer at risk for vitamin B12 deficiency, discontinue NASCOBAL
How long should I expect to take CLA before noticing effects
For doses of 10 units or less , a 30- or 50-unit insulin syringe improves readability
Large-scale human clinical trials have not yet been completed